-
公开(公告)号：US20050171009A1
公开(公告)日：2005-08-04
申请号：US11089777
申请日：2005-03-25
IPC分类号： A61K9/08 , A61K9/00 , A61K38/28 , A61K45/08 , A61K47/02 , A61K47/04 , A61K47/08 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/42 , A61P3/10 , A61K31/225 , A61K31/7024
CPC分类号： A61K31/7032 , A61K9/0019 , A61K38/28 , A61K47/26 , A61K2300/00
摘要： The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
摘要翻译： 本发明涉及包含选自胰岛素，胰岛素代谢物，胰岛素类似物，胰岛素衍生物及其组合的多肽的药物制剂; 表面活性剂或两种或更多种表面活性剂的组合; 任选的防腐剂或两种或多种防腐剂的组合; 和任选的等渗剂，缓冲剂或其它赋形剂或其组合，所述药物制剂具有在酸性范围内的pH。
-
公开(公告)号：US20100216692A1
公开(公告)日：2010-08-26
申请号：US12773356
申请日：2010-05-04
IPC分类号： A61K38/28
CPC分类号： A61K31/7032 , A61K9/0019 , A61K38/28 , A61K47/26 , A61K2300/00
摘要： The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
摘要翻译： 本发明涉及包含选自胰岛素，胰岛素代谢物，胰岛素类似物，胰岛素衍生物及其组合的多肽的药物制剂; 表面活性剂或两种或更多种表面活性剂的组合; 任选的防腐剂或两种或多种防腐剂的组合; 和任选的等渗剂，缓冲剂或其它赋形剂或其组合，所述药物制剂具有在酸性范围内的pH。
-
3.发明授权公开(公告)号：US06723429B2
公开(公告)日：2004-04-20
申请号：US09795562
申请日：2001-02-28
申请人： Holger Bengs , Jürgen Grande , Silke Schuth , Gitte Böhm , Arnold Schneller , Anette Brunner
发明人： Holger Bengs , Jürgen Grande , Silke Schuth , Gitte Böhm , Arnold Schneller , Anette Brunner
IPC分类号： B32B516
CPC分类号： C08J3/14 , C08J2305/00 , C08L3/12 , C08L5/00 , Y10T428/2982 , C08L2666/02
摘要： The present invention relates to a method for preparing smooth-surface spherical microparticles which are completely or partially made of at least one water-insoluble linear polysaccharide. This method involves dissolving the at least one water-insoluble linear polysaccharide in a solvent or a mixture of solvents, introducing the solution into a precipitation agent or a mixture of precipitation agents, optionally cooling the mixture thus obtained, and separating the microparticles thus formed. The precipitation agent used consists of at least one water-soluble cellulose derivative. This invention also relates to microparticles obtained according to this method.
摘要翻译： 本发明涉及一种完全或部分由至少一种不溶于水的线性多糖制成的光滑球形微粒的方法。 该方法包括将至少一种水不溶性线性多糖溶解在溶剂或溶剂混合物中，将溶液引入沉淀剂或沉淀剂混合物中，任选地冷却由此获得的混合物，并分离由此形成的微粒。 所用的沉淀剂由至少一种水溶性纤维素衍生物组成。 本发明还涉及根据该方法获得的微粒。
-
公开(公告)号：US07713930B2
公开(公告)日：2010-05-11
申请号：US12328208
申请日：2008-12-04
IPC分类号： A61K38/28
CPC分类号： A61K31/7032 , A61K9/0019 , A61K38/28 , A61K47/26 , A61K2300/00
摘要： The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
摘要翻译： 本发明涉及包含选自胰岛素，胰岛素代谢物，胰岛素类似物，胰岛素衍生物及其组合的多肽的药物制剂; 表面活性剂或两种或更多种表面活性剂的组合; 任选的防腐剂或两种或多种防腐剂的组合; 和任选的等渗剂，缓冲剂或其它赋形剂或其组合，所述药物制剂具有在酸性范围内的pH。
-
公开(公告)号：US07476652B2
公开(公告)日：2009-01-13
申请号：US11089777
申请日：2005-03-25
IPC分类号： A61K38/28
CPC分类号： A61K31/7032 , A61K9/0019 , A61K38/28 , A61K47/26 , A61K2300/00
摘要： The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
摘要翻译： 本发明涉及包含选自胰岛素，胰岛素代谢物，胰岛素类似物，胰岛素衍生物及其组合的多肽的药物制剂; 表面活性剂或两种或更多种表面活性剂的组合; 任选的防腐剂或两种或多种防腐剂的组合; 和任选的等渗剂，缓冲剂或其它赋形剂或其组合，所述药物制剂具有在酸性范围内的pH。
-
公开(公告)号：US09707176B2
公开(公告)日：2017-07-18
申请号：US13509507
申请日：2010-11-11
CPC分类号： A61K9/08 , A61K9/0019 , A61K38/2278 , A61K38/26 , A61K47/10 , A61K47/183 , A61P3/10
摘要： A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
-
7.发明申请公开(公告)号：US20120283179A1
公开(公告)日：2012-11-08
申请号：US13509507
申请日：2010-11-11
CPC分类号： A61K9/08 , A61K9/0019 , A61K38/2278 , A61K38/26 , A61K47/10 , A61K47/183 , A61P3/10
摘要： A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin and/or with long-acting insulin/insulin derivates where appropriate.
摘要翻译： 一种液体组合物，其包含GLP-1激动剂或/和其药理学上可耐受的盐和任选的至少一种药学上可接受的赋形剂，其中所述组合物包含甲硫氨酸，作为二甲双胍和/或长效胰岛素/ 适当的胰岛素衍生物。
-
公开(公告)号：US20090082255A1
公开(公告)日：2009-03-26
申请号：US12328208
申请日：2008-12-04
CPC分类号： A61K31/7032 , A61K9/0019 , A61K38/28 , A61K47/26 , A61K2300/00
摘要： The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.
摘要翻译： 本发明涉及包含选自胰岛素，胰岛素代谢物，胰岛素类似物，胰岛素衍生物及其组合的多肽的药物制剂; 表面活性剂或两种或更多种表面活性剂的组合; 任选的防腐剂或两种或多种防腐剂的组合; 和任选的等渗剂，缓冲剂或其它赋形剂或其组合，所述药物制剂具有在酸性范围内的pH。
-
公开(公告)号：US07097831B1
公开(公告)日：2006-08-29
申请号：US09869398
申请日：1999-11-30
申请人： Holger Bengs , Anette Brunner
发明人： Holger Bengs , Anette Brunner
IPC分类号： A01N63/00
CPC分类号： A21D2/186 , A23K10/18 , A23K20/163 , A23L7/126 , A23L29/212
摘要： The invention relates to foodstuff and animal feed which contain resistant starch on the basis of water-insoluble linear α-1,4-D-glucans. The invention also related to the utilization of resistant starch on the basis of water-insoluble linear α-1,4-D-glucans as medicaments.
摘要翻译： 本发明涉及基于水不溶性线性α-1,4-D-葡聚糖的含有抗性淀粉的食品和动物饲料。 本发明还涉及基于水不溶性线性α-1,4-D-葡聚糖作为药物的抗性淀粉的利用。
-
-
-
-
-
-
-
-
搜索结果
9 条记录 (耗时 0.021 秒)
